PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
CAMP Camp4 Therapeutics
- 5.100
- +0.580+12.83%
Close Feb 14 16:00 ET
- 5.100
- 0.0000.00%
Post 20:01 ET
102.82MMarket Cap-1.93P/E (TTM)
5.192High4.420Low32.42KVolume4.460Open4.520Pre Close156.66KTurnover0.48%Turnover RatioLossP/E (Static)20.16MShares12.30052wk High-0.65P/B34.78MFloat Cap3.50052wk Low--Dividend TTM6.82MShs Float12.300Historical High--Div YieldTTM17.07%Amplitude3.500Historical Low4.832Avg Price1Lot Size
About Camp4 Therapeutics Company
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
Company Profile
SymbolCAMP
Company NameCamp4 Therapeutics
Listing DateOct 11, 2024
Issue Price11.00
Founded2015
CEOMr. Joshua Mandel-Brehm
MarketNASDAQ
Employees58
Fiscal Year Ends12-31
AddressOne Kendall Square,Building 1400 West,3rd floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-651-8867
Websitehttp://www.camp4tx.com
Company Executives
- Name
- Position
- Salary
- Joshua Mandel-Brehm
- President, Chief Executive Officer and Director
- 696.28K
- Dr. Yuri Maricich, M.D.
- Chief Medical Officer
- --
- Kelly Gold
- Chief Financial Officer and Principal Accounting Officer
- 628.83K
- Dr. David Bumcrot, PhD
- Chief Scientific Officer and Senior Vice President of Research
- 501.93K
- Steven H. Holtzman
- Chairman of the Board and Strategic Business Advisor
- 125.00K
- Ingo Chakravarty
- Independent Director
- --
- Amir H. Nashat, PhD
- Independent Director
- --
- Dr. Paula S. Ragan, PhD
- Independent Director
- 42.50K
- James P. Boylan, M.B.A.
- Independent Director
- --
- Michael J. Higgins
- Independent Director
- 42.50K
- Jorge Conde
- Independent Director
- --
- Dr. Richard A. Young,PhD
- Independent Director
- 142.50K
- Dr. Andrew J. Schwab, PhD
- Independent Director
- --
- Dr. Ravi L. Thadhani, M.D.
- Independent Director
- 35.00K
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025